Quantcast

Latest European Union Stories

2014-08-14 08:30:05

First Patient Dosed in the EU Post-Authorization Safety Study MOUNTAIN VIEW, Calif., Aug. 14, 2014 /PRNewswire/ -- Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) today provided an update on its European Medicines Agency (EMA) post-approval studies for ADASUVE(®) inhalation powder, pre-dispensed (loxapine). As part of the ADASUVE approval process with the EMA, Alexza is required to conduct five post-approval studies: -- a benzodiazepine interaction study - study completed and data...

2014-08-13 16:20:43

Specifically designed by the international passenger rights specialist, the refund.me Red App will monitor flights booked by travel agents and flag those eligible for up to $800 in compensation NEW YORK and LONDON, Aug. 13, 2014 /PRNewswire/ -- refund.me, the international passenger rights specialist that helps flyers claim their right to compensation for flight delays, cancellations, missed connections and overbooking, has released a new app for travel agents using the Sabre...

2014-08-12 23:07:06

Latest EHS Regulations Updates Assist Companies to Achieve EHS Compliance North Vancouver, B.C., Canada (PRWEB) August 12, 2014 Specialty Technical Publishers (STP) and AECOM announce the availability of the newly updated International Audit Protocol Consortium (IAPC) EHS audit protocol for Great Britain. Leading companies around the world use IAPC EHS audit protocols to understand the scope of their EHS regulatory obligations and rapidly collect, share, archive, and export audit findings...

2014-08-11 16:27:52

LYNBROOK, N.Y., Aug. 11, 2014 /PRNewswire/ -- BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX(®) (collagenase clostridium histolyticum or CCH) in the U.S. and XIAPEX(®) in the EU, today announced its financial results for the second quarter ended June 30, 2014 and provided a corporate update. "This was a momentous quarter of milestones for XIAFLEX both commercially and clinically. We saw...

2014-08-11 04:21:59

Potentially Life-Changing Subretinal Implant Now Available at Six Leading Eye Clinics Across Germany REUTLINGEN, Germany, Aug. 11, 2014 /PRNewswire/ -- Retina Implant AG, the leading developer of subretinal implants for patients blinded by retinitis pigmentosa (RP), today announced that the Company's Alpha IMS microchip was granted NUB innovation status and will now be reimbursed by Germany's statutory health insurance system. Insuring 90 percent of the country's citizens, the German...

2014-08-08 08:26:35

First ADASUVE Launch in Latin America MOUNTAIN VIEW, Calif., Aug. 8, 2014 /PRNewswire/ -- Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) today announced that ADASUVE(®) inhalation powder, pre-dispensed (loxapine) is now available in Guatemala. This approval represents the first ADASUVE approval in Latin America for Ferrer and Alexza. Ferrer is Alexza's commercial partner for ADASUVE in the EU, Latin America and Commonwealth of Independent States countries. Ferrer introduced ADASUVE during a...

2014-08-05 16:30:39

DALLAS, August 5, 2014 /PRNewswire/ -- Spread across 157 pages, Content Delivery Networks (CDN) Market (Delivery Technologies, Hardware, Analytics, Monitoring, Encoding, Transparent Caching, DRM, CMS, OVP) - Trends, Geographical Analysis & Worldwide Market Forecasts (2014 - 2019) research report forecasts the industry to grow from $3.71 billion in 2014 to $12.16 billion by 2019, at a Compound Annual Growth Rate (CAGR) of 26.3% from 2014 to 2019. In terms of regions, North...

2014-08-05 08:41:29

Leading Enterprise Mobility Services Provider Demonstrates Commitment to Protecting Client Data BETHESDA, Md., Aug. 5, 2014 /PRNewswire/ -- Digital Management, Inc. (DMI), a leading provider of mobile enterprise and big data solutions and services, announced today that it has received the Safe Harbor certification, acknowledging its compliance with the US-EU Safe Harbor Framework developed by the United States Department of Commerce and the European Commission, demonstrating the company's...

2014-08-05 04:21:27

NESS ZIONA, Israel, August 5, 2014 /PRNewswire/ -- Atox Bio today announced that the European Commission has granted AB103 (Sodium acetate salt of the synthetic peptide H-D-Ala-Ser-Pro-Met-Leu-Val-Ala-Tyr-Asp-D-Ala-OH) orphan medicinal product designation (EU/3/14/1294) for the treatment of necrotizing soft tissue infections. Atox Bio is represented in the EU by Dr. Ulrich Granzer as agent. In addition to a 10-year period of marketing exclusivity in the EU after...

2014-08-04 08:30:36

KIGALI, Rwanda, Aug. 4, 2014 /PRNewswire-USNewswire/ -- The Government of Rwanda and the European Union (EU) on August 1, 2014 held strategic bilateral talks on how to further strengthen bilateral development cooperation. The discussions were held in Rwanda's capital Kigali. During the meeting Government updated the EU on the country's latest macroeconomic performance and medium term projections while the latter discussed implementation of the 10th European Development Fund (EDF)...


Word of the Day
tessitura
  • The prevailing range of a vocal or instrumental part, within which most of the tones lie.
This word is Italian in origin and comes from the Latin 'textura,' web, structure.